Free Trial Information
BioCentury | Oct 1, 2020
Finance

Sonoma tops off series A as it builds broader Treg therapy pipeline

...LifeForce Capital, Lilly Asia Ventures Biosciences, Octagon Capital, Alexandria Venture Investments, the JDRF T1D Fund, Milky Way Ventures and...
Read More
BioCentury | Feb 7, 2020
Emerging Company Profile

Led by Bluestone, Sonoma launches to turn Tregs against autoimmunity

...for autoimmune and neurodegenerative diseases. Sonoma’s investor syndicate includes Lyell Immunopharma Inc., Arch Venture Partners, Milky Way Ventures...
...Immunopharma Inc. Number of employees: 11 Funds raised: $40 million Investors: Lyell, Arch Venture Partners, Milky Way Ventures...
Read More
Items per page:
1 - 2 of 2
BioCentury | Oct 1, 2020
Finance

Sonoma tops off series A as it builds broader Treg therapy pipeline

...LifeForce Capital, Lilly Asia Ventures Biosciences, Octagon Capital, Alexandria Venture Investments, the JDRF T1D Fund, Milky Way Ventures and...
Read More
BioCentury | Feb 7, 2020
Emerging Company Profile

Led by Bluestone, Sonoma launches to turn Tregs against autoimmunity

...for autoimmune and neurodegenerative diseases. Sonoma’s investor syndicate includes Lyell Immunopharma Inc., Arch Venture Partners, Milky Way Ventures...
...Immunopharma Inc. Number of employees: 11 Funds raised: $40 million Investors: Lyell, Arch Venture Partners, Milky Way Ventures...
Read More
Items per page:
1 - 2 of 2